Press Releases
Catalent’s Investment in Expanding its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland, Increases to $360M
Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced a $230 million expansion project to add three further commercial-scale viral...
Press Releases
MedicalTech Innovation Forum magnifies the importance of innovation and infrastructure in the Indian medical devices industry
The launch edition of MedicalTech Innovation Forum, as Messe Frankfurt India’s first-ever hybrid conference was held at Visakhapatnam in October 2021. Experts from the healthcare industry discussed the need for optimum infrastructure, regulatory framework and innovation in the Indian...
Press Releases
Sustainable pharmaceutical practices: How Bachem is prioritizing their sustainability goals
Looking beyond the financial bottom line and showing consideration for the environment and society is a more astute business decision than usually assumed. It’s not just investors who pay attention to corporate social responsibility, it’s also consumers. More pharmaceutical...
Packaging & Labelling
Tjoapack expands into the US with the acquisition of Pharma Packaging Solutions
Tjoapack, a Netherlands-based contract packaging organisation serving the pharmaceutical industry, has acquired US-based Pharma Packaging Solutions, a leading healthcare packaging services business based in Clinton, TN. PPS provides commercial packaging and other, complementary services such as cold chain storage,...
Drug Research
Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA has authorized for emergency use a booster dose of the Moderna COVID-19 vaccine (mRNA-1273) at the 50 µg dose level for people...
Press Releases
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
Johnson & Johnson announced the U.S. FDA has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot...
Press Releases
A collaboration to enhance the delivery of biotherapeutics and generate transformative therapies for patients
Crystec Ltd. and Biosidus S.A. are delighted to announce their collaboration focused on enhancing the delivery and performance of biotherapeutics. The overarching aim of the non-exclusive partnership is to apply Crystec’s proprietary mSAS® (modified supercritical antisolvent) supercritical fluid particle...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















